Dominic Fee, MD
Neurology · Milwaukee, WINPI 1841395902
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,931 of the $6,625 with a category attached, or 89.5%. Biogen accounts for 99.7% of it on its own, with 1 other manufacturer making up the rest.
Across 11 payments — averaging $602.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$7K
- Sanofi$21
Across 116 payments — averaging $4457.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mitsubishi Tanabe Pharma Development America, Inc.$172K
- Tanabe Pharma America, Inc.$116K
- Sanofi$92K
- Mallinckrodt Enterprises LLC$40K
- PTC Therapeutics, Inc.$34K
- UCB SA$23K
- plus $40K from 3 others
What the payments were for
- Consulting fees$5,93190%
- Food & beverage$69410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,625 in reported general payments places this provider in the 85th percentile of 308 neurology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Radicava OrsEdaravone | 61 | $829,232 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 51 | $265,542 |
| NuedextaDextromethorphan Hbr/Quinidine | 39 | $71,729 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 25 | $58,267 |
| Riluzole | 72 | $10,183 |
| Gabapentin | 134 | $3,855 |
| Mycophenolate Mofetil | 35 | $2,181 |
| Tizanidine Hcl | 119 | $2,163 |
| Pregabalin | 32 | $1,669 |
| Pyridostigmine Bromide | 24 | $1,508 |
| Dantrolene Sodium | 11 | $1,216 |
| Baclofen | 42 | $1,159 |
| Nortriptyline Hcl | 24 | $756 |
| Glycopyrrolate | 12 | $462 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 16 | $356 |
Paid to pharmacies, not to this prescriber.
Other neurology in Milwaukee
- Bhupendra KhatriMilwaukee$2.5M
- Ahmed ObeidatMilwaukee$1.9M
- Staley BrodMilwaukee$1M
- Sam HooshmandMilwaukee$229K
- Fallon SchloemerMilwaukee$48K
- Thulasirman RavichandranMilwaukee$47K
- Julia CollinsMilwaukee$21K
- Ryan BrennanMilwaukee$20K
- Elise JohnsonMilwaukee$11K
- Janel SchneiderMilwaukee$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.